Kusters JG - Search Results

1

Barrett's oesophagus is characterized by a predominantly humoral inflammatory response.

Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, Tra WM, Kleinjan A, Kwekkeboom J, van Vliet AH, Siersema PD. Moons LM, et al. Among authors: kusters jg. J Pathol. 2005 Nov;207(3):269-76. doi: 10.1002/path.1847. J Pathol. 2005. PMID: 16177953

2

Bile acids and Barrett's oesophagus: a sine qua non or coincidence?

Sital RR, Kusters JG, De Rooij FW, Kuipers EJ, Siersema PD. Sital RR, et al. Among authors: kusters jg. Scand J Gastroenterol Suppl. 2006;(243):11-7. doi: 10.1080/00365520600664219. Scand J Gastroenterol Suppl. 2006. PMID: 16782617 Review.

3

High-grade dysplasia in Barrett's esophagus is associated with increased expression of calgranulin A and B.

Bax DA, Siersema PD, Haringsma J, Kuipers EJ, Vos AJ, Van Dekken H, Van Vliet AH, Kusters JG. Bax DA, et al. Among authors: kusters jg. Scand J Gastroenterol. 2007 Aug;42(8):902-10. doi: 10.1080/00365520601138189. Scand J Gastroenterol. 2007. PMID: 17613918

4

Biomarkers for risk stratification of neoplastic progression in Barrett esophagus.

Kerkhof M, Kusters JG, van Dekken H, Kuipers EJ, Siersema PD. Kerkhof M, et al. Among authors: kusters jg. Cell Oncol. 2007;29(6):507-17. doi: 10.1155/2007/814950. Cell Oncol. 2007. PMID: 18032827 Free PMC article. Review.

5

Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.

Capello A, Moons LM, Van de Winkel A, Siersema PD, van Dekken H, Kuipers EJ, Kusters JG. Capello A, et al. Among authors: kusters jg. Am J Gastroenterol. 2008 Jun;103(6):1510-6. doi: 10.1111/j.1572-0241.2008.01908.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510604

6

Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype.

Lind A, Koenderman L, Kusters JG, Siersema PD. Lind A, et al. Among authors: kusters jg. PLoS One. 2014 Aug 29;9(8):e106261. doi: 10.1371/journal.pone.0106261. eCollection 2014. PLoS One. 2014. PMID: 25170842 Free PMC article. Clinical Trial.

7

The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.

Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. Among authors: kusters jg. J Clin Pathol. 2004 Oct;57(10):1063-8. doi: 10.1136/jcp.2003.015727. J Clin Pathol. 2004. PMID: 15452161 Free PMC article.

8

MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.

Bax DA, Haringsma J, Einerhand AW, van Dekken H, Blok P, Siersema PD, Kuipers EJ, Kusters JG. Bax DA, et al. Among authors: kusters jg. J Clin Pathol. 2004 Dec;57(12):1267-72. doi: 10.1136/jcp.2004.017020. J Clin Pathol. 2004. PMID: 15563666 Free PMC article.

9

A pro-inflammatory genotype predisposes to Barrett's esophagus.

Moons LM, Kusters JG, van Delft JH, Kuipers EJ, Gottschalk R, Geldof H, Bode WA, Stoof J, van Vliet AH, Ketelslegers HB, Kleinjans JC, Siersema PD. Moons LM, et al. Among authors: kusters jg. Carcinogenesis. 2008 May;29(5):926-31. doi: 10.1093/carcin/bgm241. Epub 2008 Jan 12. Carcinogenesis. 2008. PMID: 18192685

10

Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.

Menke V, Pot RG, Moons LM, van Zoest KP, Hansen B, van Dekken H, Siersema PD, Kusters JG, Kuipers EJ. Menke V, et al. Among authors: kusters jg. J Hum Genet. 2012 Jan;57(1):26-32. doi: 10.1038/jhg.2011.124. Epub 2011 Dec 1. J Hum Genet. 2012. PMID: 22129558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page